Given the bullish talk from the company last month about January being a record month for revenue and profit and now saying that March has been a record profit and revenue month, I suspect that annual revenues for the year to 30 June will comfortably exceed $2.5 billion. Profit should be well in excess of $200m, maybe even $300m.
Unbelievable growth. Very hard to value however at say 2x revenue that’s close to $10/share. Surely with a 200-300% growth rate the multiple has to be higher than that?
- Forums
- IPOs
- VGW
Given the bullish talk from the company last month about January...
Featured News
Featured News
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online